Cart
sales@molnova.com
Decimemide
CAS No. 14817-09-5
Decimemide( —— )
Catalog No. M34570 CAS No. 14817-09-5
Decimemide (V-285) is an alkoxybenzoic acid derivative with antiepileptic activity and potential anticonvulsant activity that can be used to study neurological disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2484 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDecimemide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDecimemide (V-285) is an alkoxybenzoic acid derivative with antiepileptic activity and potential anticonvulsant activity that can be used to study neurological disorders.
-
DescriptionDecimemide (V-285) is an alkoxybenzoic acid derivative with antiepileptic activity and potential anticonvulsant activity that can be used to study neurological disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14817-09-5
-
Formula Weight337.45
-
Molecular FormulaC19H31NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N)C1=CC(OC)=C(OCCCCCCCCCC)C(OC)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
3-Benzoylpyridine
3-Benzoylpyridine is a decomposition product of HGG-12 which is the soman antidote.
-
(S)-Leucic acid
Hydroxyisocaproic acid is an end product of leucine metabolism in human tissues such as muscle and connective tissue. It belongs to 2-hydroxycarboxylic acid group of amino acid metabolites. Hydroxyisocaproic acid functions as an “anti-catabolite” and is widely used in the bodybuilding community.
-
HC-067047
HC-067047 is a potent and selective TRPV4 antagonist.Also inhibits the endogenous TRPV4-mediated response to 4α-PDH .
